Bristol Myers Squibb Net Worth (Updated 2026).

Bristol Myers Squibb, a globally recognized pharmaceutical company, traces its roots back to 1887 when it was founded by Dr. William McKinley Bristol in Clinton, New York. Initially, the company was a small-scale manufacturer of pharmaceuticals, focusing on producing quality medicines for local communities. It was during this early period that the company laid the foundation for its commitment to scientific excellence and patient care, values that remain integral to its operations today.

The turning point for Bristol Myers Squibb came in the early 20th century when it merged with the Squibb Corporation in 1933. The Squibb Corporation, founded by Dr. Edward R. Squibb in 1851, was a pioneer in the pharmaceutical industry, known for its high ethical standards and innovative products. This merger brought together two companies with a shared vision, creating a powerhouse in the pharmaceutical industry. The new entity, Bristol-Myers Company, continued to grow and expand its operations, eventually becoming the global pharmaceutical giant it is today.

Bristol Myers Squibb’s Current Net Worth (2025)

As of 2025, Bristol Myers Squibb’s current net worth is approximately $115 billion, according to the latest available information. This figure reflects the company’s strong financial performance and market position in the pharmaceutical industry.

Career

Bristol Myers Squibb, originally founded as Bristol-Myers Company in 1887, has a rich history in the pharmaceutical industry. The company has grown significantly over the years, merging with Squibb Corporation in 1989 to form Bristol-Myers Squibb, and later simplifying its name to Bristol Myers Squibb in 2020. Today, it is one of the world’s leading biopharmaceutical companies, with a strong portfolio of medicines and a commitment to innovation in healthcare.

Other Ventures

In addition to its core pharmaceutical business, Bristol Myers Squibb has several other ventures. These include its Biologics and Immunology franchise, which focuses on treatments for autoimmune diseases and cancer, and its Cardiovascular franchise, which includes medications for conditions such as high cholesterol and heart disease. The company also has a significant presence in the oncology market, with a portfolio of treatments for various types of cancer.

Assets

Bristol Myers Squibb’s assets are primarily composed of its intellectual property, including patents and trademarks, and its manufacturing facilities. The company has research and development centers around the world, as well as manufacturing sites in the United States, Europe, and Asia. Additionally, Bristol Myers Squibb holds significant cash and cash equivalents, totaling over $20 billion as of 2025.

Annual Income

Bristol Myers Squibb’s annual income, or revenue, has been consistently high in recent years. In 2020, the company reported total revenue of $45.9 billion, a 10% increase from the previous year. This growth can be attributed to strong sales of the company’s key products, including Opdivo, Eliquis, and Revlimid. The company’s annual income has been steadily increasing, reflecting its strong market position and successful product pipeline.

Frequently Asked Questions about  Bristol Myers Squibb

Frequently Asked Questions: Bristol Myers Squibb

1. What is Bristol Myers Squibb’s net worth?

Bristol Myers Squibb’s net worth is estimated to be around $150 billion.

2. When was Bristol Myers Squibb founded?

Bristol Myers Squibb was founded in 1887, making it one of the oldest pharmaceutical companies in the world.

3. What are some of the most popular drugs produced by Bristol Myers Squibb?

Bristol Myers Squibb has produced several popular drugs, including Plavix (clopidogrel), Eliquis (apixaban), Opdivo (nivolumab), and Yervoy (ipilimumab).

4. Where is Bristol Myers Squibb’s headquarters located?

Bristol Myers Squibb’s headquarters is located in New York, United States.

5. How many employees does Bristol Myers Squibb have?

As of 2021, Bristol Myers Squibb employs approximately 74,000 people worldwide.

6. What is Bristol Myers Squibb’s revenue?

Bristol Myers Squibb’s annual revenue is around $40 billion.

7. What are some of the therapeutic areas Bristol Myers Squibb focuses on?

Bristol Myers Squibb focuses on several therapeutic areas, including cancer, cardiovascular disease, diabetes, and HIV.

8. Does Bristol Myers Squibb have any acquisitions or mergers in recent years?

Yes, Bristol Myers Squibb has made several acquisitions and mergers in recent years, including the acquisition of Celgene in 2019 and the merger with Squibb in 1989.

9. What is Bristol Myers Squibb’s stock symbol?

Bristol Myers Squibb’s stock symbol is BMY and it is listed on the New York Stock Exchange (NYSE).

10. How does Bristol Myers Squibb contribute to society and sustainability?

Bristol Myers Squibb contributes to society through various initiatives, including access to medicines for underserved populations, clinical trials for diverse patient populations, and environmental sustainability efforts such as reducing greenhouse gas emissions and water usage.